{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:12:22Z","timestamp":1782123142432,"version":"3.54.5"},"reference-count":37,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Gene rearrangements affecting KMT2A are frequent in acute myeloid leukemia (AML) and are often associated with a poor prognosis. KMT2A gene fusions are often detected by chromosome banding analysis and confirmed by fluorescence in situ hybridization. However, small intragenic insertions, termed KMT2A partial tandem duplication (KMT2A-PTD), are particularly challenging to detect using standard molecular and cytogenetic approaches. Methods: We have validated the use of a custom hybrid-capture-based next-generation sequencing (NGS) panel for comprehensive profiling of AML patients seen at our institution. This NGS panel targets the entire consensus coding DNA sequence of KMT2A. To deduce the presence of a KMT2A-PTD, we used the relative ratio of KMT2A exons coverage. We sought to corroborate the KMT2A-PTD NGS results using (1) multiplex-ligation probe amplification (MLPA) and (2) optical genome mapping (OGM). Results: We analyzed 932 AML cases and identified 41 individuals harboring a KMT2A-PTD. MLPA, NGS, and OGM confirmed the presence of a KMT2A-PTD in 22 of the cases analyzed where orthogonal testing was possible. The two false-positive KMT2A-PTD calls by NGS could be explained by the presence of cryptic structural variants impacting KMT2A and interfering with KMT2A-PTD analysis. OGM revealed the nature of these previously undetected gene rearrangements in KMT2A, while MLPA yielded inconclusive results. MLPA analysis for KMT2A-PTD is limited to exon 4, whereas NGS and OGM resolved KMT2A-PTD sizes and copy number levels. Conclusions: KMT2A-PTDs are complex gene rearrangements that cannot be fully ascertained using a single genomic platform. MLPA, NGS panels, and OGM are complementary technologies applied in standard-of-care testing for AML patients. MLPA and NGS panels are designed for targeted copy number analysis; however, our results showed that integration of concurrent genomic alterations is needed for accurate KMT2A-PTD identification. Unbalanced chromosomal rearrangements overlapping with KMT2A can interfere with the diagnostic sensitivity and specificity of copy-number-based KMT2A-PTD detection methodologies.<\/jats:p>","DOI":"10.3390\/cancers16091693","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T10:56:32Z","timestamp":1714128992000},"page":"1693","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia"],"prefix":"10.3390","volume":"16","author":[{"given":"Andrew","family":"Seto","sequence":"first","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-9010","authenticated-orcid":false,"given":"Gregory","family":"Downs","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"King","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Salehi-Rad","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Baptista","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayu","family":"Chin","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Grenier","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bevoline","family":"Nwachukwu","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tierens","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada"},{"name":"Division of Hematology and Transfusion Medicine, Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[{"name":"Department of Medicine Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G 2M9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-4914","authenticated-orcid":false,"given":"Adam C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mario","family":"Capo-Chichi","sequence":"additional","affiliation":[{"name":"Genome Diagnostics & Cancer Cytogenetics Laboratories, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: A study of the Acute Myeloid Leukemia Study Group Ulm","volume":"20","author":"Tobis","year":"2002","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1200\/JCO.2008.16.7981","article-title":"Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: Individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup","volume":"27","author":"Krauter","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.leu.2401773","article-title":"Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML","volume":"14","author":"Schnittger","year":"2000","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41389-020-0191-6","article-title":"DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells","volume":"9","author":"Bera","year":"2020","journal-title":"Oncogenesis"},{"key":"ref_7","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W. (2008). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","article-title":"AML with 11q23\/MLL abnormalities as defined by the WHO classification: Incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases","volume":"102","author":"Schoch","year":"2003","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2401439","article-title":"Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants","volume":"13","author":"Satake","year":"1999","journal-title":"Leukemia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1309\/RX27R8GJQM330C22","article-title":"Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: Results in 378 adult patients","volume":"122","author":"Cox","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_11","first-page":"1918","article-title":"Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study","volume":"8","author":"Stock","year":"1994","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood.V82.12.3705.3705","article-title":"Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II","volume":"82","author":"Super","year":"1993","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"G\u00f3recki, M., Kozio\u0142, I., Kopystecka, A., Budzy\u0144ska, J., Zawitkowska, J., and Lejman, M. (2023). Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030821"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06301.x","article-title":"The MLL partial tandem duplication in acute myeloid leukaemia","volume":"135","author":"Basecke","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.1996.d01-1748.x","article-title":"Exon\/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias","volume":"93","author":"Nilson","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e201900336","DOI":"10.26508\/lsa.201900336","article-title":"Targeted variant detection using unaligned RNA-Seq reads","volume":"2","author":"Audemard","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a026658","DOI":"10.1101\/cshperspect.a026658","article-title":"Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia","volume":"7","author":"Krivtsov","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cancergen.2019.10.006","article-title":"Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia","volume":"240","author":"Vetro","year":"2020","journal-title":"Cancer Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/gcc.1132","article-title":"Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia","volume":"31","author":"Jamal","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.leu.2404024","article-title":"Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement","volume":"20","author":"Shih","year":"2006","journal-title":"Leukemia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/gcc.10219","article-title":"Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia","volume":"37","author":"Steudel","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood-2005-01-0204","article-title":"The MLL partial tandem duplication: Evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy","volume":"106","author":"Whitman","year":"2005","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.leukres.2014.11.017","article-title":"Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias","volume":"39","author":"Burmeister","year":"2015","journal-title":"Leuk. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9585","DOI":"10.1038\/s41598-022-13545-y","article-title":"FISH improves risk stratification in acute leukemia by identifying KMT2A abnormal copy number and rearrangements","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2018.205955","article-title":"Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia","volume":"104","author":"Ross","year":"2019","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jmoldx.2021.07.019","article-title":"The Application of Targeted RNA Sequencing for KMT2A\u2013Partial Tandem Duplication Identification and Integrated Analysis of Molecular Characterization in Acute Myeloid Leukemia","volume":"23","author":"Dai","year":"2021","journal-title":"J. Mol. Diagn."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1541-7786.MCR-17-0569","article-title":"Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia","volume":"16","author":"Afrin","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2015-11-683334","article-title":"Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies","volume":"128","author":"McKerrell","year":"2016","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Engvall, M., Cahill, N., Jonsson, B.-I., H\u00f6glund, M., Hallb\u00f6\u00f6k, H., and Cavelier, L. (2020). Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics. BMC Med. Genom., 13.","DOI":"10.1186\/s12920-020-00739-4"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/HS9.0000000000000181","article-title":"The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome","volume":"3","author":"Hinai","year":"2019","journal-title":"HemaSphere"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: Recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajh.26587","article-title":"Optical genome mapping for structural variation analysis in hematologic malignancies","volume":"97","author":"Smith","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ajh.27175","article-title":"A framework for the clinical implementation of optical genome mapping in hematologic malignancies","volume":"99","author":"Levy","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41467-018-08148-z","article-title":"Multi-platform discovery of haplotype-resolved structural variation in human genomes","volume":"10","author":"Chaisson","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1182\/bloodadvances.2022007613","article-title":"Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes","volume":"6","author":"Tsai","year":"2022","journal-title":"Blood Adv."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Moore, S., McGowan-Jordan, J., Smith, A.C., Rack, K., Koehler, U., Stevens-Kroeg, M., Barseghyan, H., Kanagal-Shamanna, R., and Hastings, R. (2023). Genome Mapping Nomenclature. Cytogenet. Genome Res.","DOI":"10.1159\/000535684"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/9\/1693\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:34:18Z","timestamp":1760106858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/9\/1693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["cancers16091693"],"URL":"https:\/\/doi.org\/10.3390\/cancers16091693","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}